New strategic partnership to fight heart disease

Posted by | No Tags | news | Comments Off on New strategic partnership to fight heart disease

On October 29th 2019, Ksilink has initiated two new strategic partnerships with the Biological Adaptation and Ageing research unit of the Institute of Biology Paris Seine (B2A-IBPS, Sorbonne Université/CNRS/Inserm) at the Sorbonne University and with the biotechnological company myriamed, a spinoff of the University Medical Center Göttingen. Both partnerships are pursuing a common goal: to discover new active pharmaceutical ingredients (APIs) that can help treat diseases of the heart muscle.

Click here to download the press release in English.
Click here to download the press release in French.
Click here to download the press release in German.


No Comments

Comments are closed.